Related Experiment Video
Updated: Feb 2, 2026

Ultrasound Assessment of Flow-Mediated Dilation of the Brachial and Superficial Femoral Arteries in Rats
Published on: November 3, 2016
Serum pentraxin-3 levels and flow-mediated dilation in dipper and non-dipper hypertension
Çağlar Alp1, Mehmet Tolga Dogru1, Muhammed Karadeniz1
1Faculty of Medicine, Department of Cardiology, Kırıkkale University, Kirikkale, Turkey.
Insights
Serum pentraxin-3 (PTX3) levels are higher in non-dipper hypertension patients and correlate with impaired endothelial function. This suggests PTX3 may indicate hypertension-related vascular damage.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Hypertension Pathophysiology
Background:
- Endothelial dysfunction is a key process in hypertension.
- Serum pentraxin-3 (PTX3) is a potential diagnostic and prognostic biomarker.
- Investigating PTX3 in relation to endothelial function in hypertension is of significant interest.
Purpose of the Study:
- To examine the association between serum PTX3 levels and endothelial function, measured by flow-mediated dilation (FMD).
- To compare serum PTX3 levels and FMD in dipper and non-dipper hypertensive patients.
Main Methods:
- Included 90 hypertensive patients, categorized into dipper (n=38) and non-dipper (n=52) groups using 24-hour ambulatory blood pressure monitoring.
- Assessed endothelial function noninvasively using the flow-mediated dilation (FMD) method.
Main Results:
- Serum PTX3 levels were significantly higher in non-dipper hypertension patients compared to dipper patients (P=0.028).
- A negative correlation was observed between serum PTX3 levels and the FMD basal/FMD hyperemia ratio (r=-0.297, P=0.05).
Conclusions:
- Serum PTX3 levels are closely linked to indirect noninvasive measures of endothelial function (FMD).
- Findings suggest PTX3 may serve as a relevant biomarker for endothelial dysfunction in both dipper and non-dipper hypertension.
Background:
Endothelial dysfunction is one of the main pathological processes of hypertension. The association of serum pentraxin-3 (PTX3) levels and endothelial dysfunction becomes a more interesting scientific research issue due to high potential of PTX3 as a diagnostic and prognostic biomarker. We aimed to investigate the relationship between serum PTX3 levels and flow-mediated dilation results in patients with dipper and non-dipper hypertension.
Methods:
This study included 90 hypertensive patients were divided into two groups based on 24 hours ambulatory blood pressure monitoring (ABPM): 38 patients with a dipper pattern and 52 patients with non-dipper pattern. Noninvasive evaluation of the endothelial functions was performed using flow-mediated dilation (FMD) method.
Results:
Serum pentraxin-3 levels were higher in patients with non-dipper HT compared to dipper hypertension (P = 0.028). In addition, we found negative correlation between serum PTX3 and FMD basal/FMD hyperemia ratio (r = -0.297, P = 0.05 for FMD basal/FMD hyperemia ratio, respectively).
Conclusions:
Serum PTX3 levels are closely related with the measures of indirect noninvasive evaluation methods (FMD) in both DH and NDH patients.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Leveling Effect
High-Level and Low-Level Awareness

